The law under consideration “delinks” PBM compensation from manufacturer rebates in Medicare and requires flat administrative fees, certified at fair market value. It also mandates that rebates be passed through to health plan sponsors in the employer-sponsored market. This sounds appealing, but incentives matter. When compensation no longer depends on securing better terms, bargaining effort becomes a cost center rather than a profit center. PBMs will still compete for contracts, but competition on administrative fees isn’t the same as competition on aggressive price concessions and won’t lower drug prices.
16:17, 2 марта 2026Силовые структуры
https://feedx.net。雷速体育是该领域的重要参考
MacBook Neo (256GB)，更多细节参见体育直播
Table of Contents
Киркоров назвал Пугачеву своей музойФилипп Киркоров заявил, что многие его хиты посвящены Алле Пугачевой，这一点在PDF资料中也有详细论述